{Reference Type}: Journal Article
{Title}: CURRENT CONCEPTS AND MODALITIES FOR MONITORING THE FELLOW EYE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: An Expert Panel Consensus.
{Author}: Wong TY;Lanzetta P;Bandello F;Eldem B;Navarro R;Lövestam-Adrian M;Loewenstein A;
{Journal}: Retina
{Volume}: 40
{Issue}: 4
{Year}: Apr 2020
{Factor}: 3.975
{DOI}: 10.1097/IAE.0000000000002768
{Abstract}: <B>OBJECTIVE: </B>The presence of neovascular age-related macular degeneration (nAMD) in one eye is a major risk factor for the development of disease in the fellow eye. Several methods exist to help physicians monitor the fellow eye, with new technologies becoming increasingly available.<BR><B>METHODS: </B>We provide an overview of modalities for nAMD monitoring, including advances in home-based options, and review their utility for fellow-eye monitoring, based on a review of the literature and a consensus of retinal experts.<BR><B>RESULTS: </B>Studies demonstrate the importance of early detection of nAMD in the fellow eye so that interventions can be made before significant vision loss occurs. A series of techniques exist for the early detection of nAMD including chart-based methods and imaging devices. The increased availability of home-based methods has presented an opportunity for patients to monitor their vision at home.<BR><B>CONCLUSIONS: </B>Frequent monitoring of the fellow eye in patients with unilateral nAMD is of critical importance to prevent vision loss and maintain quality of life. Patients should be examined every 3 to 4 months from the time of choroidal neovascularization diagnosis and encouraged to monitor their vision at home using home-based technologies where available, to provide the best opportunity for early detection.